Showing results (141-150 of 170) with videos related to

Sort By:
Pageof 17
Frontiers in Reproductive Health|June 25, 2025
Pregnancy and contraceptive use among participants of childbearing potential in the HVTN 705 HIV vaccine trial in Southern AfricaPamela Mda, Kathryn Mngadi, Bo Zhang, et al.
The Journal of Infectious Diseases|February 8, 2022
Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus PreventionSharana Mahomed, Nigel Garrett, Edmund V Capparelli, et al.
Plos Medicine|June 21, 2022
Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trialSimbarashe Takuva, Azwidhwi Takalani, Ishen Seocharan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2021
Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Ad26.CoV2.S Vaccination in People Living With Human Immunodeficiency Virus (HIV)Khadija Khan, Gila Lustig, Mallory Bernstein, et al.
Plos Pathogens|November 9, 2023
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infectionThandeka Moyo-Gwete, Simone I Richardson, Roanne Keeton, et al.
NPJ Vaccines|August 12, 2023
Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cellsRobert G E Krause, Thandeka Moyo-Gwete, Simone I Richardson, et al.
BMJ Open|August 28, 2023
Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trialSharana Mahomed, Nigel Garrett, Disebo Potloane, et al.
Immunity|February 7, 2016
Innate Lymphoid Cells Are Depleted Irreversibly during Acute HIV-1 Infection in the Absence of Viral SuppressionHenrik N Kløverpris, Samuel W Kazer, Jenny Mjösberg, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infectionThandeka Moyo-Gwete, Simone I Richardson, Roanne Keeton, et al.
Cell Reports|December 13, 2018
V2-Directed Vaccine-like Antibodies from HIV-1 Infection Identify an Additional K169-Binding Light Chain Motif with Broad ADCC ActivityCharmaine van Eeden, Constantinos Kurt Wibmer, Cathrine Scheepers, et al.
Pageof 17